Revenue Beat: Mold-Tek Packaging Limited Exceeded Revenue Forecasts By 5.6% And Analysts Are Updating Their Estimates
Shareholders might have noticed that Mold-Tek Packaging Limited (NSE:MOLDTKPAC) filed its first-quarter result this time last week. The early response was not positive, with shares down 6.9% to ₹656 in the past week. It was a workmanlike result, with revenues of ₹3.0b coming in 5.6% ahead of expectations, and statutory earnings per share of ₹21.93, in line with analyst appraisals. This is an important time for investors, as they can track a company's performance in its report, look at what experts are forecasting for next year, and see if there has been any change to expectations for the business. So we gathered the latest post-earnings forecasts to see what estimates suggest is in store for next year.
Taking into account the latest results, the consensus forecast from Mold-Tek Packaging's nine analysts is for revenues of ₹10.8b in 2027. This reflects a solid 14% improvement in revenue compared to the last 12 months. Statutory earnings per share are predicted to swell 19% to ₹27.28. Before this earnings report, the analysts had been forecasting revenues of ₹10.2b and earnings per share (EPS) of ₹26.95 in 2027. So it looks like there's been no major change in sentiment following the latest results, although the analysts have made a modest lift to to revenue forecasts.
See our latest analysis for Mold-Tek Packaging
It may not be a surprise to see thatthe analysts have reconfirmed their price target of ₹850, implying that the uplift in revenue is not expected to greatly contribute to Mold-Tek Packaging's valuation in the near term. Fixating on a single price target can be unwise though, since the consensus target is effectively the average of analyst price targets. As a result, some investors like to look at the range of estimates to see if there are any diverging opinions on the company's valuation. There are some variant perceptions on Mold-Tek Packaging, with the most bullish analyst valuing it at ₹1,146 and the most bearish at ₹729 per share. There are definitely some different views on the stock, but the range of estimates is not wide enough as to imply that the situation is unforecastable, in our view.
Looking at the bigger picture now, one of the ways we can make sense of these forecasts is to see how they measure up against both past performance and industry growth estimates. The analysts are definitely expecting Mold-Tek Packaging's growth to accelerate, with the forecast 19% annualised growth to the end of 2027 ranking favourably alongside historical growth of 7.9% per annum over the past five years. By contrast, our data suggests that other companies (with analyst coverage) in a similar industry are forecast to grow their revenue at 13% per year. Factoring in the forecast acceleration in revenue, it's pretty clear that Mold-Tek Packaging is expected to grow much faster than its industry.
The Bottom Line
The most important thing to take away is that there's been no major change in sentiment, with the analysts reconfirming that the business is performing in line with their previous earnings per share estimates. Happily, they also upgraded their revenue estimates, and are forecasting them to grow faster than the wider industry. There was no real change to the consensus price target, suggesting that the intrinsic value of the business has not undergone any major changes with the latest estimates.
Following on from that line of thought, we think that the long-term prospects of the business are much more relevant than next year's earnings. We have forecasts for Mold-Tek Packaging going out to 2029, and you can see them free on our platform here.
Plus, you should also learn about the 1 warning sign we've spotted with Mold-Tek Packaging .
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.